Misunderstanding the Female Athlete Triad: Refuting the IOC Consensus Statement on Relative Energy Deficiency in Sport (RED-S) by De Souza, Mary Jane et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications Nutrition and Health Sciences, Department of
2014
Misunderstanding the Female Athlete Triad:
Refuting the IOC Consensus Statement on
Relative Energy Deficiency in Sport (RED-S)
Mary Jane De Souza
The Pennsylvania State University, mjd34@psu.edu
Nancy I. Williams
The Pennsylvania State University, niw1@psu.edu
Aurelia Nattiv
University of California, Los Angeles
Elizabeth Joy
Intermountain Healthcare, Salt Lake City, Utah
Madhusmita Misra
Massachusetts General Hospital, Boston
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical
Nutrition Commons, and the Other Nutrition Commons
This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
De Souza, Mary Jane; Williams, Nancy I.; Nattiv, Aurelia; Joy, Elizabeth; Misra, Madhusmita; Loucks, Anne B.; Matheson, Gordon;
Olmsted, Marion P.; Barrack, Michelle; Mallinson, Rebecca J.; Gibbs, Jenna C.; Goolsby, Marci; Nichols, Jeanne F.; Drinkwater,
Barbara; Sanborn, Charlotte (Barney); Agostini, Rosemary; Otis, Carol L.; Johnson, Mimi D.; Hoch, Anne Zeni; Alleyne, Julia M. K.;
Wadsworth, L. Tyler; Koehler, Karsten; VanHeest, Jaci; Harvey, Paula; Kelly, Amanda K. Weiss; Fredericson, Michael; Brooks, George
A.; O'Donnell, Emma; Callahan, Lisa R.; Putukian, Margot; Costello, Lauren; Hecht, Suzanne; Rauh, Mitchell J.; and McComb,
Jacalyn, "Misunderstanding the Female Athlete Triad: Refuting the IOC Consensus Statement on Relative Energy Deficiency in Sport
(RED-S)" (2014). Nutrition and Health Sciences -- Faculty Publications. 84.
http://digitalcommons.unl.edu/nutritionfacpub/84
Authors
Mary Jane De Souza, Nancy I. Williams, Aurelia Nattiv, Elizabeth Joy, Madhusmita Misra, Anne B. Loucks,
Gordon Matheson, Marion P. Olmsted, Michelle Barrack, Rebecca J. Mallinson, Jenna C. Gibbs, Marci
Goolsby, Jeanne F. Nichols, Barbara Drinkwater, Charlotte (Barney) Sanborn, Rosemary Agostini, Carol L.
Otis, Mimi D. Johnson, Anne Zeni Hoch, Julia M. K. Alleyne, L. Tyler Wadsworth, Karsten Koehler, Jaci
VanHeest, Paula Harvey, Amanda K. Weiss Kelly, Michael Fredericson, George A. Brooks, Emma O'Donnell,
Lisa R. Callahan, Margot Putukian, Lauren Costello, Suzanne Hecht, Mitchell J. Rauh, and Jacalyn McComb
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/nutritionfacpub/84
Published in British Journal of Sports Medicine 48:20 (October 2014), pp 1461–1465. doi:10.1136/bjsports-2014-093958 
Copyright © 2014 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine.  Used by permission.
Accepted 13 June 2014; published online 18 July 2014.  
Editorial
Misunderstanding the Female Athlete Triad:  
Refuting the IOC Consensus Statement on Relative  
Energy Deficiency in Sport (RED-S)  
Mary Jane De Souza,1 Nancy I. Williams,1 Aurelia Nattiv,2 Elizabeth Joy,3 Madhusmita Misra,4  
Anne B. Loucks,5 Gordon Matheson,6 Marion P. Olmsted,7 Michelle Barrack,8 Rebecca J. Mallinson,1 
Jenna C. Gibbs,9 Marci Goolsby,10 Jeanne F. Nichols,11 Barbara Drinkwater,12  
Charlotte (Barney) Sanborn,13 Rosemary Agostini,14 Carol L. Otis,15 Mimi D. Johnson,16  
Anne Zeni Hoch,17 Julia M. K. Alleyne,7 L. Tyler Wadsworth,18 Karsten Koehler,1 Jaci VanHeest,19 
Paula Harvey,7 Amanda K. Weiss Kelly,20 Michael Fredericson,21 George A. Brooks,22  
Emma O’Donnell,7 Lisa R. Callahan,23 Margot Putukian,24 Lauren Costello,24 Suzanne Hecht,25 
Mitchell J. Rauh,26 and Jacalyn McComb27  
Author affiliations 
1 Department of Kinesiology, Pennsylvania State University, University Park, Pennsylvania, USA 
2 Division of Sports Medicine and Department of Orthopaedic Surgery, University of California, Los Angeles, California, USA 
3 Intermountain Healthcare, Salt Lake City, Utah, USA 
4 Massachusetts General Hospital, Boston, Massachusetts, USA 
5 Ohio University, Athens, Ohio, USA 
6 Stanford University School of Medicine, Stanford, California, USA 
7 University of Toronto, Toronto, Ontario, Canada 
8 University of California, Northridge, California, USA 
9 University of Waterloo, Waterloo, Ontario, Canada 
10 Hospital for Special Surgery, New York, New York, USA 
11 University of California, San Diego, California, USA 
12 Washington, USA 
13 Texas Woman’s University, Denton, Texas, USA 
14 Group Health, Seattle, Washington, USA 
15 WTA Tour Player Development, Portland, Oregon, USA 
16 University of Washington, Seattle, Washington, USA 
17 Medical College of Wisconsin, Milwaukee, Wisconsin, USA 
18 Advanced Orthopedics and Sports Medicine, St Louis, Missouri, USA 
19 University of Connecticut, Storrs, Connecticut, USA 
20 University Hospitals Case Medical Center, Cleveland, Ohio, USA 
21 Stanford University, Stanford, California, USA 
22 University of California, Berkeley, California, USA 
23 Hospital for Special Surgery, New York, New York, USA 
24 Princeton University, Princeton, New Jersey, USA 
25 University of Minnesota, Minneapolis, Minnesota, USA 
26 San Diego State University, San Diego, California, USA 
27 Texas Tech University, Lubbock, Texas, USA 
Corresponding author — Dr. Mary Jane De Souza, Women’s Health and Exercise Laboratory, 104 Noll Laboratory, Department of 
Kinesiology, Pennsylvania State University, University Park, PA 16802, USA; email mjd34@psu.edu  
1
digitalcommons.unl.edu
2 De Souza et  al .  in Brit ish Journal of  Sports  Medic ine  48 (2014)
 
An IOC consensus group has recently introduced a new 
umbrella term, that is, “Relative Energy Deficiency in Sport” 
(RED-S) to describe the physiological and pathophysiologi-
cal effects of energy deficiency in male and female athletes.1 
The authors assert that “new terminology is required to more 
accurately describe the clinical syndrome originally known 
as the Female Athlete Triad” that is a “more comprehensive, 
broader term for the overall syndrome, which includes what 
has so far been called the ‘Female Athlete Triad.’”1 This new 
terminology (RED-S) is insufficiently supported by scientific 
research to warrant adoption at this time. The Female Ath-
lete Triad has more than 30 years of published evidence to 
support its existence in the scientific literature with strong 
evidence for its clinical sequelae and should remain a focus 
of scientific inquiry and translation.2–6 Moreover, several ma-
jor concerns and errors with the IOC consensus statement 
should give researchers and practitioners great pause be-
fore adopting the IOC’s new terminology, its theoretical con-
struct and its proposed recommendations for screening and 
return to play. 
As stated by the IOC authors, the science of energy de-
ficiency in the male athlete and in other groups is still in its 
“infancy.”1 In contrast, research on the Triad has been pub-
lished since the early 1990s4 and, in fact, even earlier. Reports 
of menstrual and other problems in athletes were becom-
ing prevalent in the literature as early as the 1960s, but par-
ticularly in the 1970s and 1980s.7–10 The first symposium re-
lated to the topic at the American College of Sports Medicine 
(ACSM) Annual Meeting was organized by Barbara Drinkwa-
ter in 1981 and was entitled “Menstrual Irregularities in Fe-
male Athletes.” The term “Female Athlete Triad” was intro-
duced at a workshop in 1992.4 The first position stand from 
the ACSM was published in 1997,2 and a revised position 
stand was published in 2007.3 In 2014, a comprehensive con-
sensus paper on diagnosis, treatment and return to play on 
the Female Athlete Triad was published by the Female Ath-
lete Triad Coalition,5,6 which has been endorsed by the ACSM, 
the American Medical Society for Sports Medicine and the 
American Bone Health Alliance. The National Collegiate Ath-
letic Association in the USA has been highlighting the Coali-
tion’s Triad Consensus paper in their Sports Science Institute 
Newsletter by publishing a four-part series to highlight the 
paper and to help with dissemination of the treatment and 
return-to-play guidelines. 
While we appreciate the need for improved thinking in 
medical science, we strongly believe it is unwise and mis-
leading to propose a new approach based on faulty science. 
We strongly believe that it is unwise to distract and mislead 
the medical community from the well-known term “the Fe-
male Athlete Triad.”11 The IOC paper lacks scientific integ-
rity in two ways. First, the scientific evidence of RED-S as it 
applies to men, non- Caucasians and disabled individuals is 
in its infancy and is not sufficiently developed to warrant a 
new theoretical construct. We support the effort to call for 
more research in these populations; however, it should not 
be at the expense of a focus on and priority of the female 
athlete. Second, the IOC paper1 is fraught with errors and 
misinterpretations of the scientific literature per se. The er-
rors discussed in this paper include a flawed framework for 
the RED-S model, an incorrect representation of the Female 
Athlete Triad, applying data in women to make recommen-
dations in men, frank errors in treatment recommendations, 
a return-to-play model that is ambiguous, does not accom-
modate cumulative risk and is difficult to apply in clinical 
practice, errors in presenting the physiology of energy de-
ficiency and low energy availability and subsequent impact 
on reproductive function, errors in the diagnosis of low bone 
mineral density (BMD) in adolescents, errors in effects of es-
trogen on bone and calcium, errors in calcium and vitamin D 
recommendations and many other errors as discussed below. 
A unique feature of the IOC paper is the introduction of 
the “hub and spoke” diagram.1 However, this figure illustrates 
a poorly developed concept referred to as RED-S, and mis-
represents three decades of Triad science. What are illustrated 
as “spokes” on a wheel with a RED-S hub are the oversimpli-
fied listing of seemingly independent physiological systems, 
functions and mechanisms when in fact these physiologi-
cal systems, functions and mechanisms are not independent 
of one another, but rather interact and exhibit synergistic 
and antagonistic effects. The complex interactions of phys-
iological factors with a causal link to low energy availabil-
ity have been described and experimentally manipulated in 
studies12–19 that provide the scientific foundation for the most 
severe clinical outcomes identified in the triangle diagram il-
lustrating the Female Athlete Triad. At the center of the RED-
S hub and spoke diagram is the term “relative energy defi-
ciency” which, according to the IOC authors, refers to the 
etiological factor underpinning RED-S, that is, “an energy de-
ficiency relative to the balance between dietary energy intake 
(EI) and the energy expenditure required to support homeo-
stasis, health and the activities of daily living, growth, and 
sporting activities.” This definition of the “energy deficiency” 
component of RED-S in terms of energy balance is incongru-
ent with the definition of “energy availability” used through-
out the rest of the IOC paper.1 Energy balance and availabil-
ity are not synonymous.20 Careful work by Triad researchers 
has demonstrated that Triad conditions can be present in 
women who are in “energy balance” and thus do not exhibit 
“energy deficiency” as defined in the IOC paper, but likely 
exhibit “low energy availability” as defined and supported 
in work by Loucks and colleagues15–17,20 and included (albeit 
defined incorrectly) in the IOC paper. The psychological por-
tion of the diagram also appears independent of all other 
factors, another alarming misrepresentation, as decades of 
research in the field of eating disorders (ED) and the Triad 
would substantiate.21–23 
Another error presented in the IOC paper and its figure is 
the simplistic and underdeveloped approach to understand-
ing the Triad by implying that the Triad platform is limited 
to reproductive and skeletal issues, and that the IOC RED-S 
idea is more comprehensive. The 2007 position stand on the 
Triad3 and the 2014 consensus paper5,6 include a discussion 
of other medical issues, to include cardiovascular issues such 
as impaired endothelial vasodilation, impaired perfusion to 
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working muscles, impaired skeletal muscle oxidative metabo-
lism, lipid dysfunction, problems with the central nervous sys-
tem, gastrointestinal system and renal system. Certainly the 
psychological concerns are highlighted in all of these publi-
cations on the Female Athlete Triad2–6 when discussing dis-
ordered eating (DE) and ED. Stress fractures are a component 
of the Triad even though they are not specifically listed in the 
diagram of the Triad; likewise, metabolic and endocrine per-
turbations are mechanisms of the components of the Triad. 
Clearly, the most serious clinical sequelae of the Female Ath-
lete Triad include ED, reproductive disorders and skeletal out-
comes. In particular, negative bone outcomes are especially 
concerning since they are questionably irreversible, 2,3,5,6 and 
as such, are highlighted in the framing of the terminology of 
the Triad. Such a highlight on the most serious clinical se-
quelae benefits many athletes who suffer from these clinical 
outcomes, and does not exclude other outcomes. The Triad 
framework is also most favorable for knowledge translation 
to the most frequently affected population, namely young 
female athletes and exercising women. Alternatively, the in-
troduction of a new term (RED-S), and a new (flawed) illus-
tration of the physiology of the syndrome diffuses the mes-
saging about the heightened susceptibility to and severity of 
effects of the Triad in girls and women, and places too much 
emphasis on “sport,” thus overshadowing the many recre-
ational athletes that are similarly affected.11,24,25 
The IOC paper incorrectly claims the recognition that en-
ergy deficiency can impact male athletes as something new; 
this is not new and Triad researchers and others have been al-
luding to this concern since 1993. The first 1993 ACSM work-
shop paper4 and the 19972 as well as the 20073 versions of the 
ACSM Triad position stands indicate that further research is 
necessary to explore clinical outcomes in male athletes. Al-
though several studies have documented the existence of 
Triad-like conditions in male cyclists,26,27 judoists28 and horse 
jockeys,29 almost two decades later few data exist to support 
the existence of serious clinical sequelae in men relative to 
those in women that result from energy deficiency. 
Meanwhile, there is good reason to suspect that sex differ-
ences protect men against the serious clinical consequences of 
energy deficiency that afflict women. Testosterone promotes 
bone as well as muscle growth, and effects of low testosterone 
on bone formation are different from the effects of low estro-
gen on bone resorption.30,31 Testosterone endows men with 
wider bones that are less susceptible to fracture.32 Further-
more, the energetic costs of reproduction are much lower in 
men than in women.33 Men do not have to “fuel” ovarian and 
menstrual cycles, let alone gestation and lactation. Evidence 
of effects of low energy availability on sperm count and mo-
tility is largely nonexistent, in part because egg cells mature 
by growing in size, whereas sperm cells mature by shrinking. 
Sperm do not store large quantities of energy derived from the 
male body, and inside women they derive their fuel for motil-
ity from the female body. For these and other reasons, repro-
ductive and skeletal disorders may occur in men in extreme 
energy deficiency, but a prevalence as high as that in women 
at less severe levels of energy deficiency is doubtful. 
Many more studies should document a concerning prev-
alence of physiological and clinical consequences of low en-
ergy availability in male athletes before a new term is in-
troduced for those specific conditions in men. Moreover, 
the recent studies documenting ED and low bone density 
in men34–36 deserve to be extended without bias stemming 
from existing literature in women. It has taken decades to 
learn that important sex differences exist in male and female 
physiology, and we should not repeat previous mistakes by 
establishing clinical guidelines for both sexes when there are 
data primarily only for one sex. It is misleading in this regard 
that the risk stratification and return-to-play guidelines in the 
IOC paper are developed mostly from studies in women,1 in-
clude few male-specific end points and ignore that imple-
mentation problems will exist if applied to male athletes. The 
preceding concerns of lack of data and the errors in applying 
clinical guidelines to more than one population are magni-
fied when other issues such as race, ethnicity and ability are 
considered. The point made by the IOC authors that low en-
ergy availability has serious consequences in male athletes, 
non-Caucasians and individuals with disabilities is important, 
but there is no evidence for their recommendation. Indeed, 
their recommendations should have stopped at advocating 
for more research and should not have extended to screen-
ing, treatment and return-to-play recommendations. 
The IOC authors propose a new risk assessment and re-
turn-to-play model, “Red Light-Yellow Light-Green Light,” rep-
resenting high-risk, moderate-risk and low-risk athletes, re-
spectively.1 Concerning is both the lack of evidence and lack 
of quantification behind some of the risk factors noted within 
this framework. For example, the lack of clarity and quan-
tification of “yellow light” risk factors, such as “prolonged 
abnormally low per cent body fat,” “prolonged energy defi-
ciency” and “lack of progress in treatment,” makes each one 
of them difficult to interpret in the return-to-play schema. 
Likewise, this framework does not take into account cumu-
lative risk in a quantitative way that can be measured over 
time to assess improvement or decline. Similarly, the return-
to-play categories noted in table 3 do not provide the cli-
nician any guidance as to the number of risk factors within 
each category that warrant the return-to-play recommen-
dations. As such, adopting the IOC return-to-play model will 
lead to ambiguous decision-making. 
The IOC paper is also weakened by the authors’ disregard 
for accuracy when referencing scientific literature. The IOC 
paper1 is fraught with fundamental errors and misinterpre-
tations of the literature. Several of these errors are described 
below. Generally speaking, the paper is poorly referenced 
throughout. There are many instances where inaccurate ref-
erences are used, several instances where statements are not 
referenced and many instances where original research is 
not referenced. The most important and blatant errors are 
listed below. 
Hormonal and Metabolic Imbalance Section 
1. The authors state that “Abnormal levels of hormones, 
LH pulsatility, inadequate body fat stores, low energy 
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availability (EA) and exercise stress may be etiological 
factors in menstrual disorders in athletes. Marked re-
duction in EA may disrupt the LH pulsatility by affect-
ing the hypothalamic hormone gonadotropin-releasing 
hormone (GnRH) output which subsequently alters the 
menstrual cycle.” These statements are incorrect. The hy-
pothalamus can make GnRH in varying amounts or pat-
terns (GnRH output) in different states of energy avail-
ability, but it is specifically abnormal GnRH pulsatility that 
impacts gonadotropin pulsatility, as opposed to GnRH 
output, and that leads to amenorrhoea.37 
2. The authors state that “Subtle menstrual dysfunction, such 
as very light bleeding, mildly extended menstrual inter-
val and premenstrual and postmenstrual spotting may 
occur, and may be underestimated by routine screen-
ing.” De Souza et al24 is cited for this statement. Although 
De Souza et al24 reported that subtle menstrual distur-
bances are prevalent among physically active women, it 
was highlighted that these subtle menstrual disturbances 
are difficult to detect clinically. In addition, there is no 
mention of light bleeding or spotting in the De Souza 
et al24 paper. 
Health and Performance Section 
1. The authors state that “hormonal and metabolic abnormal-
ities caused by RED-S and carbohydrate deficiency can 
result in a decreased production of growth hormone.” 
This statement is incorrect. Low EA is associated with 
an increase in growth hormone, which is most likely a 
result of reduced circulating insulin-like growth factor 
1 (IGF1) concentrations and hepatic growth hormone 
resistance.38,39 
2. The authors state that “Oestrogen increases uptake of cal-
cium into blood and deposition into bone, while pro-
gesterone facilitates the actions of oestrogen through 
multiple complex mechanisms.” This is also inaccurate. 
Estrogen acts by inhibiting osteoclast activity, not by in-
creasing uptake of calcium into blood and deposition 
in bone.40 Calcium absorption from the gut is driven by 
1,25(OH)2 vitamin D.41 It is not clear what (if any) bone 
effects of estrogen are facilitated by progesterone and 
how. No original research references are provided to 
support the proposed progesterone effects on bone in 
the IOC paper. 
3. The authors state that testosterone stimulates osteoclast 
activity. Testosterone does not stimulate osteoclast ac-
tivity. Testosterone directly stimulates osteoblast activ-
ity thereby upregulating bone formation,30,42 and may 
inhibit osteoclast activity through its aromatization to es-
trogen (which has primarily antiresorptive effects). 
4. The authors state that “DE/ED in male jockeys are associ-
ated with low BMD” and cite Dolan et al29 as a reference 
for this statement. This is an inaccurate reference for this 
statement. Dolan et al29 did not assess DE or ED in their 
study. Rather, Dolan et al29 report that low BMD in jock-
eys was associated with low IGF-1 and elevated sex hor-
mone-binding globulin concentrations. 
Screening and Diagnosis Section 
Bone health 
The authors state that “In the adolescent, DXA should in-
clude the whole body (head excluded) in addition to the lum-
bar spine… A value below −2.0 SD is considered as osteo-
porosis with the presence of secondary clinical risk factors.” 
This statement requires clarification. The International Soci-
ety of Clinical Densitometry (ISCD) recommends assessment 
of lumbar spine or whole body sites for assessment of bone 
density in adolescents, and while it prefers the assessment of 
whole body less head (to whole body), when technically fea-
sible, it does not indicate that whole body BMD assessment 
should not be performed.43 In addition, the ISCD defines os-
teoporosis in adolescents as low bone density z-scores ( ≤−2) 
with a history of clinically significant fracture43 and not a low 
bone density z-score alone. This stand has been reiterated in 
the 2013 position statement from the ISCD.44,45 It is impor-
tant to clarify this and to indicate what conditions constitute 
secondary clinical risk factors. 
Treatment Section 
1. For the section regarding weight gain and improvement 
in bone density, the authors state “However, full recov-
ery may not be feasible, as bone microarchitecture is 
also impaired.” The reason for lack of full recovery is not 
that bone architecture is also impaired. Impaired bone 
architecture is a consequence of many of the same fac-
tors that lead to low bone density.46,47 Lack of full re-
covery of bone parameters is likely consequent to in-
complete recovery of certain hormonal changes (such 
as cortisol elevation) despite an improvement in en-
ergy status.48 
2. The authors recommend that the “athlete diet should in-
clude 1500 mg/ day of calcium.” The reference that is 
cited for that statement49 does not directly state that 
1500 mg/day is the appropriate calcium intake for ath-
letes. Rather, the article provides guidelines for how to 
counsel individuals about appropriate calcium intake, 
but does not recommend a certain intake. Furthermore, 
the appropriate calcium intake for athletes is not men-
tioned in the article.49 The current recommended dietary 
allowance for calcium from the 2011 Institute of Medi-
cine guidelines is 1300 mg/day for adolescents and 1000 
mg/day for young adults.50,51 According to the Ameri-
can Academy of Pediatrics Committee on Sports Medi-
cine and Fitness,52 and others,53 it is recommended that 
amenorrhoeic athletes intake 1500 mg of calcium per 
day. As such, this is an example of a statement that uses 
imprecise wording and is not properly referenced. 
3. The authors state that “Programmes of high-impact load-
ing and resistance training should be implemented at 
least 2–3 days/week for athletes in non-weight-bearing 
sports and/or those with decreased BMD.” This statement 
is not supported by any reference. In fact, one may argue 
that high-impact loading activity may precipitate frac-
tures in amenorrhoeic women with very low bone den-
sity. This issue is not discussed. 
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4. The authors state that leptin “can be used to stimulate ap-
petite.” On the contrary, leptin is an anorexigenic hor-
mone and therefore suppresses appetite54–56 and, in fact, 
recombinant leptin administration is associated with sup-
pression of appetite and weight loss in women with func-
tional hypothalamic amenorrhoea.57, 58 
5. The authors state that “The Endocrine Society Guideline 
(2011) recommends maintaining vitamin D [25(OH)D] 
blood levels above 32–50 ng/mL, with 1500–2000 IU/
day of vitamin D.” This is inaccurate. The guidelines are 
as follows.59 “We recommend using the serum circulating 
25(OH)D level, measured by a reliable assay, to evaluate 
vitamin D status in patients who are at risk for vitamin D 
deficiency. Vitamin D deficiency is defined as a 25(OH)
D below 20 ng/ml (50 nmol/liter), and vitamin D insuffi-
ciency as a 25(OH)D of 21–29 ng/ml (525–725 nmol/li-
ter),” and “We suggest that adults aged 19–50 yr require 
at least 600 IU/d of vitamin D to maximize bone health 
and muscle function. It is unknown whether 600 IU/d is 
enough to provide all the potential non-skeletal health 
benefits associated with vitamin D. However, to raise the 
blood level of 25(OH)D consistently above 30 ng/ml may 
require at least 1500–2000 IU/d of vitamin D.” The Endo-
crine Society guidelines do not provide a recommended 
target range for vitamin D. 
6. The authors state that “use of the oral hormonal contra-
ceptive pills in athletes with functional hypothalamic 
amenorrhea have been reported to have a detrimen-
tal effect on BMD through the suppression of androgen 
secretion and cause premature closure of the epiphy-
ses compromising growth of the long bones in adoles-
cents.” The authors cite Scheid et al.60 Scheid et al60 is the 
wrong reference as that paper has nothing to do with 
any of these factors. 
7. Throughout the treatment section, no critical analysis of 
randomized controlled trials versus prospective studies 
is presented and no source literature is referenced. This 
is a major flaw as treatment recommendations are in-
cluded in the IOC paper. In addition, treatment recom-
mendations for bone health in men are not based on 
studies in male athletes. 
Summary 
We are concerned that readers of the IOC paper will be 
confused and misled by the poorly referenced statements 
and frank (and sometimes dangerous) errors in the paper. The 
IOC authors should publish a correction of these and other 
errors noted. Broadening research of low energy availability 
in other groups, such as the male athlete, athletes of diverse 
ethnicities and the disabled athlete may help to advance sci-
ence and may one day warrant introduction of a specific term 
for whatever serious clinical sequelae of energy deficiency 
may be discovered in future research on men. 
Research on the “Female Athlete Triad” has forged a plat-
form from which a broad array of healthcare providers (e.g., 
physicians, sport dietitians, mental health professionals and 
athletic trainers) have made great strides in learning how to 
manage and treat affected women. Research on the “Female 
Athlete Triad” has also been translated to the lay public such 
that more and more affected female athletes and exercising 
women willingly seek education, prevention and treatment. 
Meanwhile, subsuming the term “Female Athlete Triad” 
under the umbrella of the term RED-S has the potential to 
confuse rather than enlighten, and undo decades of work 
educating and advocating for awareness, prevention and 
treatment for the Triad. The individual most impacted by the 
de-emphasis on the Triad will be the female athlete herself. 
The overwhelming clinical importance of the Female Athlete 
Triad compared with other conditions under the proposed 
RED-S umbrella will continue to make a specific reference for 
the Triad useful for those who deal with it, including physi-
cians, coaches, sport dietitians, athletics trainers, parents and, 
most importantly, female athletes. As such, efforts promoting 
awareness, prevention and treatment of the Female Athlete 
Triad remain critically important and should not be overshad-
owed by an ill-conceived and poorly defended new construct. 
Signed by the authors of the 1993 Triad naming paper, the 
1997 and 2007 Triad position stands, and the 2014 Triad Con-
sensus paper. Contributors MJDS, NIW, AN, EJ, MM, ABL, RJM 
and KK were involved in the drafting, reviewing and editing 
of the manuscript. All other authors reviewed and edited the 
manuscript.  
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